Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Next Science Limited
  6. News
  7. Summary
    NXS   AU0000041329

NEXT SCIENCE LIMITED

(NXS)
  Report
Delayed Australian Stock Exchange  -  07:16:40 2023-02-06 pm EST
0.6900 AUD   +4.55%
02/01Transcript : Next Science Limited - Shareholder/Analyst Call
CI
2022Next Science Limited announced that it expects to receive AUD 10 million in funding from Walker Group Holdings Pty Limited
CI
2022Next Science Secures AU$10 Million in Convertible Notes; Shares Down 4%
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Transcript : Next Science Limited Presents at ShareCafe Small Cap "Hidden Gems" Webinar, Oct-27-2022 09:30 PM

10/27/2022 | 09:30pm EST
Thank you, everyone for joining today's ShareCafe ASX Hidden Gems Webinar, which I should point out, is a direct result of the hard work of the team, who looked deep into the ASX to find genuine...


ę S&P Capital IQ 2022
All news about NEXT SCIENCE LIMITED
02/01Transcript : Next Science Limited - Shareholder/Analyst Call
CI
2022Next Science Limited announced that it expects to receive AUD 10 million in funding fro..
CI
2022Next Science Secures AU$10 Million in Convertible Notes; Shares Down 4%
MT
2022Transcript : Next Science Limited Presents at ShareCafe Small Cap "Hidden Gem..
CI
2022Next Science's Collagen Products Secure Medicare Accreditation in the US; Shares Jump 8..
MT
2022Next Science Limited Announces the Launch of Topical Collagen Products
CI
2022Next Science Secures License for Wound Cleaning Product in Canada
MT
2022Next Science Limited Announces Health Canada Given Licensing Approval for XPERIENCE
CI
2022Transcript : Next Science Limited, H1 2022 Earnings Call, Aug 25, 2022
CI
2022Next Science Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
More news
Financials (USD)
Sales 2022 11,3 M - -
Net income 2022 -11,0 M - -
Net cash 2022 9,56 M - -
P/E ratio 2022 -10,1x
Yield 2022 -
Capitalization 97,4 M 97,4 M -
EV / Sales 2022 7,77x
EV / Sales 2023 4,84x
Nbr of Employees -
Free-Float 47,5%
Chart NEXT SCIENCE LIMITED
Duration : Period :
Next Science Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEXT SCIENCE LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 0,45 $
Average target price 0,90 $
Spread / Average Target 99,3%
EPS Revisions
Managers and Directors
Judith Mitchell Chief Executive Officer, Director & MD
Jacqueline Butler Chief Financial Officer
Mark R. Compton Independent Non-Executive Chairman
Matthew Myntti Chief Technology Officer
Jeanne Lee VP-Regulatory Affairs & Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
NEXT SCIENCE LIMITED-8.76%93
JOHNSON & JOHNSON-6.82%430 370
ELI LILLY AND COMPANY-7.31%322 186
NOVO NORDISK A/S0.37%309 611
ROCHE HOLDING AG-2.81%269 030
MERCK & CO., INC.-7.22%260 994